$43.31
+0.90 (+2.12%)
Open$42.06
Previous Close$42.41
Day High$43.38
Day Low$41.89
52W High$54.85
52W Low$28.54
Volume—
Avg Volume848.0K
Market Cap1.60B
P/E Ratio—
EPS$-0.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-43.1% upside
Current
$43.31
$43.31
Target
$24.64
$24.64
$15.17
$24.64 avg
$37.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 279.97M | 192.56M | 753.50M |
| Net Income | -5,283,777 | -3,270,788 | 117.60M |
| Profit Margin | -1.9% | -1.8% | 15.6% |
| EBITDA | 25.38M | 16.58M | 185.25M |
| Free Cash Flow | — | — | 80.89M |
| Rev Growth | +45.4% | +45.4% | +23.8% |
| Debt/Equity | 4.64 | 4.64 | 0.62 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |